The coronavirus pandemic has placed extraordinary demands on the healthcare industry and the groups that are interconnected with the healthcare industry. The strain on obtaining adequate resources to establish a baseline of trending symptomatic patients and severity levels is spreading across the country. While many patients who may be exposed to the emerging threat of COVID-19 have accessible means to seek immediate testing and treatment, many more patients do not. It is that sentiment that we drive toward aggregating data to help our partners and broader organizations achieve innovation parity of a vaccine that all patients can afford.

Download our discovery report.